|Bid||1.0500 x 45100|
|Ask||1.0800 x 1400|
|Day's Range||1.0800 - 1.1286|
|52 Week Range||1.0600 - 3.5800|
|Beta (5Y Monthly)||0.99|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 04, 2021 - Aug 09, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||4.00|
Potential Savara Inc. ( NASDAQ:SVRA ) shareholders may wish to note that the Independent Director, David Ramsay...
AUSTIN, Texas, November 15, 2021--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will present at the following healthcare conferences:
AUSTIN, Texas, November 12, 2021--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today reported financial results for the third quarter ending September 30, 2021 and provided a business update.